Prediction of late normal tissue complications in RT treated gynaecological cancer patients: Potential of the γ-H2AX foci assay and association with chromosomal radiosensitivity

Oncology Reports

Volumn 23, Issue 2, 2010, Pages 571-578

  Werbrouck, Joke ^a   De Ruyck, Kim ^a   Beels, Laurence ^a   Vral, Anne ^a   Van Eijkeren, Marc ^b   De Neve, Wilfried ^b   Thierens, Hubert ^a  

^a GHENT UNIVERSITY   (Belgium)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

H2AX foci; DNA DSB repair; Gynaecological cancer; Late normal tissue complications; Radiosensitivity assay

Indexed keywords

GAMMA HISTONE H2AX; HISTONE H2AX; UNCLASSIFIED DRUG;

ARTICLE; ASSAY; CHROMATID; CLINICAL ARTICLE; CONTROLLED STUDY; DNA REPAIR; DOUBLE STRANDED DNA BREAK; FEMALE; GYNECOLOGIC CANCER; HUMAN; IN VITRO STUDY; IRRADIATION; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; SCORING SYSTEM; T LYMPHOCYTE;

ADULT; AGED; CARCINOMA; CHROMOSOMES, HUMAN; FEMALE; FOLLOW-UP STUDIES; GENITAL NEOPLASMS, FEMALE; HISTONES; HUMANS; MIDDLE AGED; MOLECULAR DIAGNOSTIC TECHNIQUES; PROGNOSIS; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RISK FACTORS; TIME FACTORS; TUMOR STEM CELL ASSAY;

EID: 76649087375     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00000671     Document Type: Article

References (33)

1. Ahamad A and Jhingran A: New radiation techniques in gynecological cancer. Int J Gynecol Cancer 14: 569-579, 2004.
2. Gabelova A, Farkasova T, Gurska S, Machackova Z, Lukacko P and Witkovsky V: Radiosensitivity of peripheral blood lymphocytes from healthy donors and cervical cancer patients; the correspondence of in vitro data with the clinical outcome. Neoplasma 55: 182-191, 2008.
3. Tewari KS and DiSaia PJ: Radiation therapy for gynecologic cancer. J Obstet Gynaecol Res 28: 123-140, 2002.
4. Tucker SL, Geara FB, Peters LJ and Brock WA: How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal tissue radiosensitivity? Radiother Oncol 38: 103-113, 1996.
5. Andreassen CN, Alsner J and Overgaard J: Does variability in normal tissue reactions after radiotherapy have a genetic basis - where and how to look for it. Radiother Oncol 64: 131-140, 2002.
6. Andreassen CN: Can risk of radiotherapy-induced normal tissue complications be predicted from genetic profiles? Acta Oncol 44: 801-815, 2005.
7. Peacock J, Ashton A, Bliss J, et al: Cellular radiosensitivity and complication risk after curative radiotherapy. Radiother Oncol 55: 173-178, 2000.
8. De Ruyck K, van Eijkeren M, Claes K, et al: Radiation-induced damage to normal tissues after radiotherapy in patients treated for gynecologic tumors: association with single nucleotide polymorphisms in XRCC1, XRCC3 and OGG1 genes and in vitro chromosomal radiosensitivity in lymphocytes. Int J Radiat Oncol Biol Phys 62: 1140-1149, 2005.
9. Willems P, Claes K, Baeyens A, et al: Polymorphisms in nonhomologous end joining genes associated with breast cancer risk and chromosomal radiosensitivity. Genes Chromosomes Cancer 47: 137-148, 2008.
10. Barber JBP, Burrill W, Spreadborough AR, et al: Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol 55: 179-186, 2000.
11. Bourguignon MH, Gisone PA, Perez MR, Michelins S, Dubner D, Giorgio MD and Carosella ED: Genetic and epigenetic features in radiation sensitivity. Part II: Implications for clinical practice and radiation protection. Eur J Nucl Med Mol Imaging 32: 351-368, 2005.
12. Marková E, Schultz N and Belyaev IY: Kinetics and dose-response of residual 53BP1/γ-H2AX foci: co-localisation, relationship with DSB repair and clonogenic survival. Int J Radiat Biol 83: 319-329, 2007.
13. Alapetite C, Thirion P, De la Rochefordière A, Cosset J and Moustacchi E: Analyisis by alkaline comet assay of cancer patients with severe reactions to radiotherapy: defective rejoining of radioinduced DNA strand breaks in lymphocytes of breast cancer patients. Int J Cancer 83: 83-90, 1999.
14. Löbrich M, Rief N, Kühne M, Heckmann M, Fleckenstein J, Rübe C and Uder M: In vivo formation and repair of DNA double-strand breaks after computed tomography examinations. Proc Natl Acad Sci USA 102: 8984-8989, 2005.
15. Werbrouck J, De Ruyck K, Duprez F, et al: Acute normal tissue reactions in head-and neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes. Int J Radiat Oncol Biol Phys 73: 1187-1195, 2009.
16. Andreassen CN, Alsner J, Overgaard M and Overgaard J: Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes. Radiother Oncol 69: 127-135, 2003.
17. Rogakou EP, Pilch DR, Orr AH, Ivanova VS and Bonner WM: DNA double stranded breaks induce histone H2AX phosphorylation on Serine 139. J Biol Chem 273: 5858-5868, 1998.
18. Rogakou EP, Boon C, Redon C and Bonner WM: Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 146: 905-915, 1999.
19. Rothkamm K and Löbrich M: Evidence for a lack of DNA double-strand break repair in human cells exposed to very low X-ray doses. Proc Natl Acad Sci USA 100: 5057-5062, 2002.
20. Kao J, Milano MT, Javaheri A, Garofalo MC, Chmura SJ, Weichselbaum RR and Kron SJ: γ-H2AX as a therapeutic target for improving the efficacy of radiation therapy. Curr Cancer Drug Targets 6: 197-205, 2006.
21. Bassing CH, Chua KF, Sekiguchi J, et al: Increased ionizing radiation sensitivity and genomic instability in the absence of histone H2AX. Proc Natl Acad Sci USA 99: 8173-8178, 2002.
22. Downs AJ, Lowndes NF and Jackson SP: A role for Saccharomyces cerevisiae histone HA in DNA repair. Nature 408: 1001-1004, 2000.
23. Olive PL and Banáth J: Phosphorylation of histone H2AX as a measure of radiosensitivity. Int J Radiat Oncol Biol Phys 58: 331-335, 2004.
24. Available at: http://www.hgvs.org/mutnomen. Accessed February 9, 2007.
25. Kato TA, Nagasawa H, Weil MM, Little JB and Bedford JS: Levels of γ-H2AX foci after low-dose-rate irradiation reveal a DNA DSB rejoining defect in cells from human ATM heterozygotes in two AT families and in another apparently normal individual. Radiat Res 166: 443-453, 2006.
26. Johansen J, Bentzen SM, Overgaard J and Overgaard M: Evidence for a positive correlation between in vitro radio-sensitivity of normal human skin fibroblasts and the occurrence of subcutaneous fibrosis after radiotherapy. Int J Radiat Biol 69: 407-412, 1994.
27. Wang W, Chen Z, Li D, et al: Detecting normal cell radio-sensitivity via assay of DNA damage in lymphocytes for individualizing radiotherapy in head and neck cancer patients. Oncology 69: 208-213, 2005.
28. MacPhail SH, Banáth JP, Yu TY, Chu EHM, Lambur H and Olive PL: Expression of phosphorylated histone H2AX in cultured cell lines following exposure to X-rays. Int J Radiat Biol 79: 351-358, 2003.
29. Banáth JP, MacPhail SH and Olive PL: Radiation sensitivity, H2AX phosphorylation, and kinetics of repair of DNA strand breaks in irradiated cervical cancer cell lines. Cancer Res 64: 7144-7149, 2004.
30. Klokov D, MacPhail SM, Banáth JP, Byrne JP and Olive PL: Phosphorylated histone H2AX in relation to cell survival in tumor cells and xenografts exposed to single and fractionated doses of X-rays. Radiother Oncol 80: 223-229, 2006.
31. Taneja N, Davis M, Choy JS, Beckett MA, Singh R, Kron SJ and Weichselbaum RR: Histone H2AX phosphorylation as a predictor of radiosensitivity and target for radiotherapy. J Biol Chem 279: 2273-2280, 2004.
32. Rübe CE, Grudzenski S, Kühne M, Dong X, Rief N, Löbrich M and Rübe C: DNA double strand break repair of blood lymphocytes and normal tissues analysed in a preclinical mouse model: implications for radiosensitivity testing. Clin Cancer Res 14: 6546-6555, 2008.
33. Olive PL, Banáth JP and Keyes M: Residual γH2AX after irradiation of human lymphocytes and monocytes in vitro and its relation to late effects after prostate brachytherapy. Radiother Oncol 86: 336-346, 2008.